Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Abbott Laboratories receives CE Mark for TECNIS Symfony extended range of vision intraocular lens for cataract patients


Tuesday, 24 Jun 2014 09:00am EDT 

Abbott Laboratories:Receives CE Marking (Conformite Europeenne) in Europe for TECNIS Symfony Extended Range of Vision intraocular lens (IOL) for treatment of cataract patients who also have diminished ability to focus on near objects (presbyopia).Standard IOLs can be used in cataract treatment to improve distance vision.But TECNIS Symfony IOL is first-of-its kind lens that is intended to provide patients continuous range of vision including far, intermediate and near distances with reduced incidence of halo and glare comparable to monofocal lens (1).This IOL is not approved for use in the United States. 

Company Quote

44.32
0.51 +1.16%
24 Nov 2014